Literature DB >> 23934117

LOX-1, a new marker of risk and prognosis in coronary artery disease?

Valter Lubrano1, Silvana Balzan.   

Abstract

The development of atherosclerosis is caused by the accumulation of lipid, inflammatory cytokine production, and the large amount of inflammatory cells in the arterial wall. It is now established that the presence of oxidized low-density lipoproteins (ox-LDL) has an important role in the pathogenesis of the disease. There are many scavenger receptors for ox-LDL, among which LOX-1 seems to be important for the induction of endothelial dysfunction and the other subsequent events that lead to the formation of atheromatous plaque. Our findings indicate the presence of a regulatory role induced by the presence of ox-LDL on LOX-1 through the amplification of IL-6 synthesis. This mechanism contributes to the upregulation of the ORL-1 gene expression in presence of risk factors. Many authors have shown the possibility to use LOX-1 as a good marker for the diagnosis and prognosis of coronary artery disease because it is easy to measure and more sensitive than other markers commonly used in the routine of laboratory medicine.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23934117     DOI: 10.1007/s11010-013-1770-z

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  59 in total

1.  Identification of soluble forms of lectin-like oxidized LDL receptor-1.

Authors:  T Murase; N Kume; H Kataoka; M Minami; T Sawamura; T Masaki; T Kita
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

2.  Inhibition of LOX-1 by statins may relate to upregulation of eNOS.

Authors:  J L Mehta; D Y Li; H J Chen; J Joseph; F Romeo
Journal:  Biochem Biophys Res Commun       Date:  2001-12-14       Impact factor: 3.575

Review 3.  Oxidized low-density lipoprotein and atherosclerosis implications in antioxidant therapy.

Authors:  Sona Mitra; Abhishek Deshmukh; Rajesh Sachdeva; Jingjun Lu; Jawahar L Mehta
Journal:  Am J Med Sci       Date:  2011-08       Impact factor: 2.378

4.  Activation of lectin-like oxidized low-density lipoprotein receptor-1 induces apoptosis in cultured neonatal rat cardiac myocytes.

Authors:  E Iwai-Kanai; K Hasegawa; T Sawamura; M Fujita; T Yanazume; S Toyokuni; S Adachi; Y Kihara; S Sasayama
Journal:  Circulation       Date:  2001-12-11       Impact factor: 29.690

5.  Activation-dependent surface expression of LOX-1 in human platelets.

Authors:  M Chen; M Kakutani; T Naruko; M Ueda; S Narumiya; T Masaki; T Sawamura
Journal:  Biochem Biophys Res Commun       Date:  2001-03-23       Impact factor: 3.575

6.  Interleukin-6 stimulates LDL receptor gene expression via activation of sterol-responsive and Sp1 binding elements.

Authors:  H Gierens; M Nauck; M Roth; R Schinker; C Schürmann; H Scharnagl; G Neuhaus; H Wieland; W März
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-07       Impact factor: 8.311

7.  Fluid shear stress transcriptionally induces lectin-like oxidized LDL receptor-1 in vascular endothelial cells.

Authors:  T Murase; N Kume; R Korenaga; J Ando; T Sawamura; T Masaki; T Kita
Journal:  Circ Res       Date:  1998-08-10       Impact factor: 17.367

8.  LOX-1 deletion alters signals of myocardial remodeling immediately after ischemia-reperfusion.

Authors:  Changping Hu; Abhijit Dandapat; Jiawei Chen; Yoshiko Fujita; Nobutaka Inoue; Yosuke Kawase; Kou-ichi Jishage; Hiroshi Suzuki; Tatsuya Sawamura; Jawahar L Mehta
Journal:  Cardiovasc Res       Date:  2007-07-18       Impact factor: 10.787

9.  Genetic variation in lectin-like oxidized low-density lipoprotein receptor 1 (LOX1) gene and the risk of coronary artery disease.

Authors:  Qi Chen; Steven E Reis; Candace Kammerer; Wendy Y Craig; Sue E LaPierre; Erin Luedecking Zimmer; Dennis M McNamara; Daniel F Pauly; Barry Sharaf; Richard Holubkov; C Noel Bairey Merz; George Sopko; Franklin Bontempo; M Ilyas Kamboh
Journal:  Circulation       Date:  2003-06-16       Impact factor: 29.690

10.  Genotyping OLR1 gene: a genomic biomarker for cardiovascular diseases.

Authors:  Lucia Vecchione; Elisa Gargiul; Paola Borgiani; Irene Predazzi; Ruggiero Mango; Francesco Romeo; Mauro Magnani; Giuseppe Novelli
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2007-06
View more
  4 in total

1.  Serum lectin-like oxidized-low density lipoprotein receptor-1 and adiponectin levels are associated with coronary artery disease accompanied with metabolic syndrome.

Authors:  Ali Sheikh Md Sayed; Zhenyu Zhao; Lanyan Guo; Fei Li; Xu Deng; Hai Deng; Ke Xia; Tianlun Yang
Journal:  Iran Red Crescent Med J       Date:  2014-08-05       Impact factor: 0.611

2.  A fermented bean flour extract downregulates LOX-1, CHOP and ICAM-1 in HMEC-1 stimulated by ox-LDL.

Authors:  Morena Gabriele; Laura Pucci; Margherita La Marca; Daniela Lucchesi; Clara Maria Della Croce; Vincenzo Longo; Valter Lubrano
Journal:  Cell Mol Biol Lett       Date:  2016-08-12       Impact factor: 5.787

3.  Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.

Authors:  Teodora Stankova; Ginka Delcheva; Ana Maneva; Stefka Vladeva
Journal:  Medicina (Kaunas)       Date:  2019-08-15       Impact factor: 2.430

4.  Interleukin-1β Promotes Ox-LDL Uptake by Human Glomerular Mesangial Cells via LOX-1.

Authors:  Hua Liu; Yinping Li; Na Lin; Xingtong Dong; Wen Li; Yinghui Deng; Lina Ma
Journal:  Int J Med Sci       Date:  2020-04-27       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.